当前位置：首页 > 文献互助 > 互助详情

Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II Trial复制

用户nbKVFDd9wZJE 1天前 33 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-07-08 16:27:13 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1158/1078-0432.CCR-24-2444复制

文献链接: https://aacrjournals.org/clincancerres/article/30/24/5577/750421/Anlotinib-plus-TQB2450-a-PD-L1-Antibody-in复制

其他信息:

出版社: American Association for Cancer Research (AACR)
作者: Zhichao Tan; Yan Wu; Zhengfu Fan; Tian Gao; Wei Guo; Chujie Bai; Ruifeng Xue; Shu Li; Lu Zhang; Xinyu Wang; Ling Jia; Jiayong Liu
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-24-2444/3512322/ccr-24-2444.pdf

上一篇：Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II Trial

下一篇：Difficult-to-treat rheumatoid arthritis: systematic review and meta-analysis on global prevalence

互助时间线

2026-07-01 16:37:35 [完结求助]

楼主确认了笑出声来应助的文件是正确的, 求助状态变成 已完结

2026-07-01 16:27:13 [上传文件]

笑出声来上传了文件(pdf 7.11 MB), 求助状态变成 待确认

2026-07-01 16:06:14 [发起求助]

最新发布的求助

Covalent organic frameworks (COFs): from design to applications 42分钟前
Neuroprotective effects of Gastrodia elata and its compounds in a Caenorhabditis elegans Alzheimer’s disease model 1小时前
Baicalin alleviates pathological changes in Alzheimer's disease comorbid with type 2 diabetes: Targeting metabolic dysregulation and neuroinflammation 1小时前
Integrated untargeted and targeted metabolomics to reveal the mechanisms of herbal medicine HLXLD on Alzheimer's disease 1小时前
Dihuang Yinzi Regulates cAMP/PKA/CREB-BDNF to Improve Synaptic Plasticity in APP/PS1 Mice: A Study Based on Brain Metabolomics 1小时前
Total Lignans From Leaves of Schisandra chinensis Improve Alzheimer's Disease Pathology Through the Nrf2/HO-1/NLRP3 Pathway 1小时前
RANQSAR: a standalone open-source application for reproducible machine learning-based QSAR analysis 1小时前
Efficacy and safety of Ivarmacitinib in moderate-to-severe atopic dermatitis patients with or without previous systemic treatments: a post-hoc analysis of a phase III trial 1小时前
24-Week Real-World Effectiveness and Safety of Lebrikizumab for Atopic Dermatitis in Japan: An Analysis Stratified by Prior Systemic Therapy 1小时前
48-Week Real-World Outcomes of Lebrikizumab Treatment for Atopic Dermatitis: Systemic Therapy-Naive Versus -Experienced Patients 2小时前
Resolving cellular dynamics using single-cell temporal transcriptomics 2小时前
Constructing Protein-Scaffolded Multienzyme Assembly Enhances the Coupling Efficiency of the P450 System for Efficient Daidzein Biosynthesis from (2S)-Naringenin 3小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com